8-K: Modular Medical Faces Nasdaq Delisting Warning Over Sub-$1 Share Price

Modular Medical, Inc. received a notice from Nasdaq indicating non-compliance with the minimum $1 bid price requirement, initiating a 180-day period to regain compliance.

Summary

• Modular Medical, Inc. received a letter from The Nasdaq Stock Market LLC on June 30, 2025, notifying the company of non-compliance with Nasdaq Listing Rule 5550(a)(2).
• The non-compliance stems from the company's common stock closing bid price falling below the required $1 per share for 30 consecutive business days, ending June 27, 2025.
• The company has been granted a 180-calendar day period, until December 29, 2025, to regain compliance.
• To regain compliance, the closing bid price of the common stock must be at least $1 per share for a minimum of ten consecutive business days during this period.
• If compliance is not regained within the initial 180 days, the company may be eligible for an additional 180-day period provided it meets other Nasdaq Capital Market listing standards (excluding bid price) and intends to cure the deficiency, potentially through a reverse stock split.
• Failure to cure the deficiency could lead to Nasdaq providing notice that the common stock will be subject to delisting.
• The letter does not result in immediate delisting of the company's common stock from the Nasdaq Capital Market.

Sentiment

Score: 3

Explanation: The document indicates a significant negative event (Nasdaq non-compliance and delisting risk), which typically signals financial distress or lack of investor confidence. While there's a compliance period, the underlying issue is negative.

Positives

• The notice does not result in the immediate delisting of the company's common stock from the Nasdaq Capital Market.
• Modular Medical has a 180-day compliance period to address the bid price deficiency.

Negatives

• Modular Medical's common stock failed to maintain the minimum $1 bid price requirement for 30 consecutive business days.
• The company is at risk of delisting from The Nasdaq Stock Market if it cannot regain compliance within the specified period.

Risks

• Potential delisting of common stock from The Nasdaq Stock Market LLC if the minimum bid price requirement is not met.
• Risk of not being able to maintain a closing bid price of at least $1 per share for ten consecutive business days.
• Potential need for a reverse stock split to cure the bid price deficiency, which can dilute existing shareholder value.
• Uncertainty regarding eligibility for an additional compliance period if the initial period expires without compliance.

Future Outlook

Modular Medical is actively monitoring the closing bid price of its common stock and evaluating available options to regain compliance with Nasdaq's minimum bid price requirement. The company may consider a reverse stock split if necessary to cure the deficiency during a potential second compliance period.

Industry Context

Receiving a Nasdaq bid price non-compliance notice is a common occurrence for smaller public companies whose stock prices have declined. It highlights the challenges faced by companies in maintaining market capitalization and investor confidence, particularly in volatile market conditions or during periods of operational challenges. Such notices often precede strategic actions like reverse stock splits aimed at boosting share price to meet listing requirements.

Stakeholder Impact

• Shareholders: Face the risk of delisting, which could reduce liquidity and investor interest in the stock. A potential reverse stock split could also impact their share count and perception of value, though it doesn't change total equity.
• Company: Faces operational and strategic pressure to increase its stock price or risk losing its Nasdaq listing, which can impact its ability to raise capital and its public profile.

Next Steps

• Modular Medical will monitor the closing bid price of its common stock.
• The company will consider available options to regain compliance with Nasdaq's minimum bid price requirement.
• Potentially, the company may effect a reverse stock split if necessary to cure the deficiency during a second compliance period.

Key Dates

Recommendation

Keywords

Nasdaq, delisting, bid price, non-compliance, MODD, common stock, stock market, regulatory notice, 8-K, reverse stock split